Pure Global

LIFEGUARD Study - Continuous Respiratory Monitoring on the General Ward - Trial NCT03571646

Access comprehensive clinical trial information for NCT03571646 through Pure Global AI's free database. This phase not specified trial is sponsored by Medtronic - MITG and is currently Terminated. The study focuses on Respiratory Complication. Target enrollment is 6 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT03571646
Terminated
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT03571646
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
LIFEGUARD Study - Continuous Respiratory Monitoring on the General Ward

Study Focus

Respiratory Complication

Capnostream 20 monitoring

Interventional

behavioral

Sponsor & Location

Medtronic - MITG

Bonn,Marburg, Germany

Timeline & Enrollment

N/A

May 09, 2019

Dec 14, 2019

6 participants

Primary Outcome

Quantify the Incidence and Severity of Post-operative Respiratory Compromise Markers

Summary

The purpose of this study is to document how often and how severe are the breathing
 difficulties that patients suffer, while recovering on a general ward following a serious
 operation

ICD-10 Classifications

Respiratory disorder, unspecified
Other respiratory disorders
Respiratory failure, unspecified
Other postprocedural respiratory disorders
Other specified respiratory disorders

Data Source

ClinicalTrials.gov

NCT03571646

Non-Device Trial